elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26767169-C85D1331-930A-4FAE-A36D-8A9D4E480849
Q26767169-C85D1331-930A-4FAE-A36D-8A9D4E480849
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26767169-C85D1331-930A-4FAE-A36D-8A9D4E480849
Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma
P2860
Q26767169-C85D1331-930A-4FAE-A36D-8A9D4E480849
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26767169-C85D1331-930A-4FAE-A36D-8A9D4E480849
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64037ac46c46595708b8ec7f962e3d32c083d4eb
P2860
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.